FDA Inspection 1306592 — ICON Clinical Research LLC
The FDA completed an inspection of ICON Clinical Research LLC on February 4, 2026 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, NY (United States)
Additional Details
Sponsor, Contract Research Organization